ArticleInternational journal of nanomedicine2023

Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer.

Wan-Ling Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.